Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 141 (1995), 371-375
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karasawa, T.
Right arrow Articles by Nakamura, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karasawa, T.
Right arrow Articles by Nakamura, S.
Agricola
Right arrow Articles by Karasawa, T.
Right arrow Articles by Nakamura, S.

microbiology, Vol 141, 371-375, Copyright © 1995 by Society for General Microbiology


ARTICLES

A defined growth medium for Clostridium difficile

T Karasawa, S Ikoma, K Yamakawa and S Nakamura
Department of Bacteriology, School of Medicine, Kanazawa University, Japan.

Minimal requirements of amino acids and vitamins were determined in chemically defined medium for five strains of Clostridium difficile. Cysteine, isoleucine, leucine, proline, tryptophan and valine were essential amino acids for growth of C. difficile. Arginine, glycine, histidine, methionine and threonine enhanced growth. Biotin, pantothenate and pyridoxine were essential vitamins. A defined medium containing the minimal requirements of amino acids and vitamins produced a rapid and heavy growth which was comparable to that in modified brain heart infusion, a complex medium. Adenine was able to substitute for glycine and threonine, suggesting that the two amino acids may be utilized as precursors of purine nucleotides. The defined medium developed here will assist physiological and biochemical studies on C. difficile.


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
S. Jackson, M. Calos, A. Myers, and W. T. Self
Analysis of Proline Reduction in the Nosocomial Pathogen Clostridium difficile
J. Bacteriol., December 15, 2006; 188(24): 8487 - 8495.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Karlsson, B. Dupuy, K. Mukherjee, E. Norin, L. G. Burman, and T. Akerlund
Expression of Clostridium difficile Toxins A and B and Their Sigma Factor TcdD Is Controlled by Temperature
Infect. Immun., April 1, 2003; 71(4): 1784 - 1793.
[Abstract] [Full Text]


Home page
J Med MicrobiolHome page
T. MAEGAWA, T. KARASAWA, T. OHTA, X. WANG, H. KATO, H. HAYASHI, and S. NAKAMURA
Linkage between toxin production and purine biosynthesis in Clostridium difficile
J. Med. Microbiol., January 1, 2002; 51(1): 34 - 41.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Karlsson, A. Lindberg, E. Norin, L. G. Burman, and T. Akerlund
Toxins, Butyric Acid, and Other Short-Chain Fatty Acids Are Coordinately Expressed and Down-Regulated by Cysteine in Clostridium difficile
Infect. Immun., October 1, 2000; 68(10): 5881 - 5888.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1995 Society for General Microbiology.